This research article from Nature Cancer explores how malignant cells reprogram their environment by physically transferring mitochondria to nearby fibroblasts. Using advanced imaging and genetic tracing, the authors demonstrate that this exchange occurs through tunneling nanotubes, thin bridges that connect the cells. Once they receive these foreign organelles, the fibroblasts undergo a metabolic shift and transform into cancer-associated fibroblasts (CAFs), which then actively support tumor growth. The study identifies the protein MIRO2 as the essential motor for this transport, noting that its depletion effectively halts the transformation process. These findings highlight a novel mechanism of tumorigenesis where cancer cells "infect" healthy stromal cells to create a more hospitable environment for progression. By validating these results in both mouse models and human skin cancer samples, the researchers provide a strong rationale for developing therapies that target mitochondrial trafficking to disrupt the tumor microenvironment.

References:

• Cangkrama M, Liu H, Wu X, et al. MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation[J]. Nature Cancer, 2025, 6(10): 1714-1733.